Revital Healthcare EPZ Ltd. Achieves WHO Prequalification for Early-Activation Auto-Disable Syringe: A Milestone for African Manufacturing and Immunization Programming
Official Press Release
The early-activation feature is the gold standard for safety in Immunization programs as preferred by UNICEF, and renders the syringe disabled at the start of administering and injection. Historically, the introduction of these devices have resulted in substantial reductions in rates of blood-borne infections such as HIV in immunization programs across Africa.
There are currently eight manufacturers who have WHO PQ status for this product, however Revital’s is the first and only to be produced in Africa. This is expected to decrease average syringe transport times by up to 80-90% for Africa, critical for rapid outbreak response and timely immunization campaigns.
Roneek Vora, Director of Marketing and Sales for Revital Healthcare EPZ Ltd., comments, “Revital’s historic WHO pre-qualification for the early-activation AD syringe exemplifies the transformative power of African innovation and manufacturing excellence. Our commitment to the well-being of our fellow people, especially children receiving life-saving immunization, is our motivation to continue to progress.”
Revital will be able to produce upwards of 300 million AD syringes per year.
This work was made possible through a grant from the Bill & Melinda Gates Foundation. In addition to supporting the development of this product to increase supply security for Africa, this helped create more than 200 new local jobs in Kilifi County, 80% of which are staffed by women in support of a joint commitment to gender equality.
“As the first African manufacturer to be approved by WHO to produce early activation auto-disable syringes, Revital is paving the way to expand local production of syringes,” said Violaine Mitchell, Director of Immunization at the Bill & Melinda Gates Foundation.
“We are proud to support Revital’s efforts to sustainably expand the supply of these syringes in Africa and ensure vaccines are delivered safely and quickly across the continent.”
The WHO PQ listing for the 0.5ml early-activation AD syringe can be accessed through the WHO Vaccine Quality Catalogue.
First African Manufacturer
Impact and Innovation
Enhanced Syringe Safety
Impact On Global Healthcare
Reduced Medical Waste
Have Any Questions?
Manufacturing Capacity Annually
New Jobs Generated
Manufacturing Capacity Annually
New jobs generated
What is Revital's early activation auto-disable (AD) syringe?
Why is Revital's AD syringes important in healthcare?
How will Revital's AD syringes improve immunization programs?
Is Revital's AD syringe compatible with different medications and vaccines?
What are the environmental benefits of Revital's AD syringes?
State Of The Art
Head Of International BD
Our Patent Holders
Buzz on WHO Prequalification
Latest News & Resources
Blog News &UpdatesRevital Healthcare banks blanket contractfrom a key global organisationRevital Healthcare has recently secured a notable contract with a global organization to supply India with 50 million units of 2ML vaccine syringes amidst concerns over a...
Blog News &UpdatesRevital becomes sole company in African to manufacture Covid-19 vaccine syringesRevital Healthcare (EPZ) Limited has gained international recognition for its efforts in the fight against the Covid-19 pandemic. The company has earned the...
Blog News &UpdatesUkraine using Revital-made bCPAP device to save premature babiesPremature babies in Ukraine with breathing difficulties are being saved by a device made in Kenya. The bCPAP device, produced by Africa's largest medical manufacturer - Revital...
Blog News &UpdatesRevital Exported 70 Million Covid-19 Vaccine SyringesRevital Healthcare has been globally acknowledged for its role in exporting more than 70 million Covid-19 vaccine syringes during the pandemic. The then President of Kenya, Uhuru Kenyatta,...
Blog News &UpdatesRevital unveils bCPAP - first-ever non-electric respiratory device to save babiesRevital Healthcare has achieved a remarkable feat by becoming the world's first manufacturer of a respiratory device specifically designed to support neonates and...
Blog News &UpdatesRevital Healthcare receives $3.9 million grantfrom Bill & Melinda Gates FoundationRevital Healthcare (EPZ) Limited, has made an exciting announcement today. The prestigious Bill & Melinda Gates Foundation has granted the company a...